Not applicableStudy completedNCT02116257
What this trial is testing
The Opioid-sparing Effect and Reduced PONV Using Propacetamol in PCA Among Patients With High Risk of PONV
Who this might be right for
PONVPropacetamol
Yonsei University 108
Showing 6 of 6 results